Effect of Sacubitril/Valsartan or Enalapril on Left Ventricular Function in Patients With Hematologic Malignancies Treated With Bone Marrow Transplantation
Treatment with sacubitril/valsartan or enalapril prevented deterioration of myocardial function at 6 months in patients with hematologic malignancies treated with BMT. Moreover, sacubitril/valsartan showed a more favorable effect on myocardial work indices. (Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation; NCT04092309).
Authors
- D Vythoulkas (ORCID: https://orcid.org/0000-0003-3965-1663)
- J Thymis (ORCID: https://orcid.org/0000-0002-3916-5350)
- Ignatios Ikonomidis (ORCID: https://orcid.org/0000-0001-8241-7886)
- Georgia-Angeliki Koliou (ORCID: https://orcid.org/0000-0002-4205-5080)
- Panagiotis Tsirigotis (ORCID: https://orcid.org/0000-0002-3522-3680)
- Dimitrios T. Farmakis (ORCID: https://orcid.org/0000-0001-8364-3447)
- Κ Katogiannis (ORCID: https://orcid.org/0000-0003-1631-5210)
- George Makavos (ORCID: https://orcid.org/0000-0002-1123-8060)
- Maria Stamouli
- D Tsilivarakis
Institutions
- National and Kapodistrian University of Athens (GR)
- University General Hospital Attikon (GR)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101628
- Citations
- 3
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 4.16